REFERENCES
- Simons D G, Travell J G, Simons L S. Travell and Simons' Myofascial Pain and Dysfunction: The Trigger Point Manual, Vol. 1, 2nd ed. Williams and Wilkins, Baltimore 1999
- Travell J G, Simons D G. Myofascial Pain and Dysfunction: The Trigger Point Manual, Vol. 2. Williams and Wilkins, Baltimore 1992
- Fischer A A, Chang C H. Temperature and pressure threshold measurements in trigger points. Thermology 1986; 1: 212–215
- Ojala T, Arokoski J P, Partanen J. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: A double-blind, randomized, and controlled crossover trial. Clin J Pain 2006; 22: 90–96
- Ferrante F M, Bearn L, Rothrock R, King L. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. Anesthesiology 2005; 103: 377–383
- Wheeler A H, Goolkasian P, Gretz S S. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 1998; 23(15)1662–1666
- Wheeler A H, Goolkasian P, Gretz S S. Botulinum toxin A for the treatment of chronic neck pain. Pain 2001; 94: 255–260
- Freund B J, Schwartz M. Treatment of whiplash associated neck pain corrected with botulinum toxin-A: A pilot study. J Rheumatol 2000; 27: 481–484
- Göbel H, Heinze A, Reichel G, Hefter H, Benecke R. Efficacy and safety of a single botulinum type A toxin complex treatment [Dysport] for the relief of upper back myofascial pain syndrome: Results from a randomized double-blind placebo-controlled multicentre study. Pain 2006; 125(1–2)82–88
- Gur A, Sarac A J, Cevik R, Altindag O, Sarac S. Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: A double-blind and randomize-controlled trial. Lasers Surg Med 2004; 35(3)229–235
- Fernández-de-las-Peñas C, Arendt-Nielsen L, Simons D G. Contributions of myofascial trigger points to chronic tension type headache. J Man Manipulative Ther 2006; 14(4)222–231
- Shah J P, Phillips T M, Danoff J V, Gerber L H. An in-vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 2005; 99: 1977–1984
- Shah J P, Danoff J V, Desai M J, Parikh S, Nakamura L Y, Phillips T M, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil 2008; 89(1)16–23
- Iwama H, Akama Y. The superiority of water-diluted 0.25% to near 1% lidocaine for trigger-point injections in myofascial pain syndrome: A prospective, randomized, double-blinded trial. Anesth Analg 2000; 91(2)408–409
- Dommerholt J, Mayoral O, Gröbli C. Trigger point dry needling. J Man Manipulative Ther 2006; 14(4)E70–E87